Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-European stocks post worst week since October on vaccine woes

Fri, 29th Jan 2021 08:20

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* STOXX 600 down 3% on the week

* Ericsson jumps on upbeat earnings

* H&M slides as it fears loss in Q1
(Updates to market close)

By Sruthi Shankar

Jan 29 (Reuters) - European stocks slid on Friday, recording
their worst weekly performance since October as concerns around
the slow rollout of COVID-19 vaccines mount, while a retail
trading frenzy led to volatility on Wall Street.

The benchmark STOXX 600 index closed 1.9% lower,
erasing all of January's gains and ending the week down 3.1%

Germany's DAX fell 1.7%, the UK's blue-chip FTSE
100 dropped 1.8% and U.S. stocks fell more than 1% after
underwhelming COVID-19 vaccine data from Johnson & Johnson
.

Concerns around the potential economic damage from a new
strain of the coronavirus in Europe and delays to vaccine
rollouts have dented sentiment in the past few days.

In the U.S., where the stock market enjoyed a stimulus-led
rally last year, volatility was seen following steep gains in
heavily shorted stocks, including Gamestop and AMC
Entertainment after retail traders piled in.

Europe's medicines regulator approved AstraZeneca
and Oxford University's COVID-19 vaccine for people over the age
of 18 on Friday, the third vaccine to be cleared for use in the
European Union.

Europe urgently needs more shots to speed up its inoculation
programme, with AstraZeneca, Pfizer and Moderna
facing difficulties in delivering the shipments to the bloc.

"We're postponing the recovery story a little bit because of
the lockdown measures and challenges for European growth," said
Joseph Little, global chief strategist at HSBC Global Asset
Management, London.

"I'm still optimistic on parts of Europe which have lagged
rather badly, economically and in markets. They could begin to
perform as the cyclical catch-up becomes more important."

Economy-linked stocks of banks, insurers,
miners and oil & gas companies were among the
worst hit this week but Germany and Spain's economies recorded
growth in the fourth quarter, while the French economy
contracted by a smaller than expected rate.

In a busy day for earnings, Sweden's Ericsson
jumped 7.6% after reporting fourth-quarter core earnings ahead
of market estimates on the back of strong sales of 5G equipment.

Daimler edged up 0.9% after it said a strong
fourth quarter helped it post better-than-expected 2020 group
operating profit and that it was optimistic for 2021.

Swedish fashion retailer H&M fell 5.0% as it braced
for a loss in the first quarter after full-year profits
plummeted due to COVID-19.

Europe's earnings season has been largely positive so far.
Of the 8% of STOXX 600 companies that have reported, 78% have
topped profit estimates, according to Refinitiv IBES data.
(Reporting by Sruthi Shankar in Bengaluru; editing by Bernard
Orr and Elaine Hardcastle)

More News
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.